For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Latin America precision medicine market
Precision medicine is a combination of molecular biology techniques and system biology. Big data analytics is expected t- drive the market in Latin America. Latin American countries like Brazil, Mexic- and Argentina are focusing on providing personalized treatment and therapies t- the population, with the use of technologies like next-generation sequencing (NGS), data analytics, etc. Pharmaceuticals and biotech companies are expected t- drive the market during the forecast period of 2018-2023, due t- the emergence of drug discovery technologies. According t- Netscribes, the Latin America precision medicine market is expected t- expand at a compound annual growth rate (CAGR) of 9.35% leading t- a revenue of USD 6.48 Bn by 2023.
Owing t- huge investments in diagnostic research and development in Latin America, there is ample scope for the market t- grow during the forecasted period of 2018-2023. Advancements in drug discovery technology, companion diagnostics, next-gene sequencing (NGS), etc will aid market growth in the coming years.
The Latin America precision medicine market is classified int- three primary segments: based on ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies); based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases); and based on technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics).
In the technology segment, drug discovery holds the largest share in the Latin American precision medicine market, whereas big data analytics is expected t- grow at the highest CAGR. Cancer comprises of the maximum share in the therapeutics segment due t- the higher mortality rate due t- cancer.
Key growth factors
Advancements in healthcare technology, demand for personalized medical solutions and treatments are the factors driving the precision medicine market in Latin America. The market is als- being driven by favorable government laws and regulations for precision medicine. Due t- these reasons the precision medicine market is expected t- grow at a high CAGR.
Threats and key players
Public healthcare spending in the Latin American countries like Mexic- and Brazil is low. S- adoption of precision medicine and advanced healthcare support calls for high out-of-pocket spending, which can hinder the growth of the market. Around 31% of the Latin American population cannot access healthcare for economic reasons. Under such circumstances, the development and use of precision medicines can be challenging.
Major players in the Latin America precision medicine market are Pfizer, Novartis, Teva Pharmaceuticals Industries etc.
What's covered in the report?
1. Overview of the Latin America precision medicine market.
2. Market drivers and challenges in the Latin America precision medicine market.
3. Market trends in the Latin America precision medicine market.
4. Historical, current and forecasted market size data for the Latin America precision medicine market segmentation by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies) - by revenue (USD Bn).
5. Historical, current and forecasted market size data for the Latin America precision medicine market segmentation by therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases) - by revenue (USD Bn).
6. Historical, current and forecasted market size data for the Latin Americaprecision medicine market segmentation by technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics) - by revenue (USD Bn).
7. Historical, current and forecasted country-wise (Brazil, Mexic- and Argentina) market size data (USD Bn) for the Latin America precision medicine market and its segmentations by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies), by therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases), and by technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics).
8. Analysis of the competitive landscape and profiles of major companies operating in the market.
Why buy?
1. Understand the demand for precision medicine market t- determine the viability of the market.
2. Determine the developed and emerging markets where precision medicine market is provided.
3. Identify the challenge areas and address them.
4. Develop strategies based on the drivers, trends and highlights for each of the segments.
5. Evaluate the value chain t- determine the workflow and t- get an idea of the current position where you are placed.
6. Recognize the key competitors of this market and respond accordingly.
7. Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.
8. Define the competitive positioning by comparing the products and services with the key players in the market.
Customizations available
With the given market data, Netscribes offers customizations according t- specific needs. Write t- us at [email protected].